Ventyx Biosciences, Inc. (VTYX)
NASDAQ: VTYX · Real-Time Price · USD
1.180
-0.020 (-1.67%)
At close: May 14, 2025, 4:00 PM
1.230
+0.050 (4.24%)
After-hours: May 14, 2025, 5:44 PM EDT
Ventyx Biosciences Market Cap
Ventyx Biosciences has a market cap or net worth of $83.97 million as of May 14, 2025. Its market cap has decreased by -69.69% in one year.
Market Cap
83.97M
Enterprise Value
-133.22M
1-Year Change
-69.69%
Ranking
Category
Stock Price
$1.18
Market Cap Chart
Since the IPO on October 21, 2021, Ventyx Biosciences's market cap has decreased from $782.89M to $83.97M, a decrease of -89.27%. That is a compound annual growth rate of -46.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 13, 2025 | 85.39M | -44.86% |
| Dec 31, 2024 | 154.86M | 6.21% |
| Dec 29, 2023 | 145.80M | -92.15% |
| Dec 30, 2022 | 1.86B | 85.92% |
| Dec 31, 2021 | 998.89M | 27.59% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.08B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |